These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18444931)

  • 21. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of hamster hearts in presensitized rats.
    Lin Y; Soares MP; Sato K; Csizmadia E; Robson SC; Smith N; Bach FH
    J Immunol; 2000 May; 164(9):4883-92. PubMed ID: 10779798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against complement component C5 prevent antibody-mediated rejection after lung transplantation in murine orthotopic models with skin-graft-induced pre-sensitization.
    Shiina Y; Suzuki H; Hata A; Kaiho T; Matsumoto H; Toyoda T; Sakairi Y; Wada H; Motohashi S; Yoshino I
    Gen Thorac Cardiovasc Surg; 2022 Dec; 70(12):1032-1041. PubMed ID: 35767165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Complement C5 Small-interfering RNA Lipid Nanoparticle Prolongs Graft Survival in a Hypersensitized Rat Kidney Transplant Model.
    Ishigooka H; Katsumata H; Saiga K; Tokita D; Motoi S; Matsui C; Suzuki Y; Tomimatsu A; Nakatani T; Kuboi Y; Yamakawa T; Ikeda T; Ishii R; Imai T; Takagi T; Tanabe K
    Transplantation; 2022 Dec; 106(12):2338-2347. PubMed ID: 35749284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
    Vincenti F; Ramos E; Brattstrom C; Cho S; Ekberg H; Grinyo J; Johnson R; Kuypers D; Stuart F; Khanna A; Navarro M; Nashan B
    Transplantation; 2001 May; 71(9):1282-7. PubMed ID: 11397963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells.
    Ge W; Jiang J; Liu W; Lian D; Saito A; Garcia B; Li XC; Wang H
    Am J Transplant; 2010 Aug; 10(8):1760-73. PubMed ID: 20636455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?
    Cetrulo CL; Torabi R; Scalea JR; Shimizu A; Leto Barone AA; Gillon BC; Tasaki M; Leonard DA; Cormack TA; Villani V; Randolph MA; Sachs DH; Yamada K
    Transplantation; 2013 Dec; 96(11):966-74. PubMed ID: 24056624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of blood transfusion and cyclophosphamide on cardiac allograft survival in sensitized mice.
    Lasek W; Sora M; Jakóbisiak M
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):399-403. PubMed ID: 8572899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
    Lin CH; Wang YL; Anggelia MR; Chuang WY; Cheng HY; Mao Q; Zelken JA; Lin CH; Zheng XX; Lee WP; Brandacher G
    Am J Transplant; 2016 Jul; 16(7):2030-41. PubMed ID: 26914847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.